Literature DB >> 183238

Radioimmunoassay measurement of ACTH-facilitated PGE2 and PGF2alpha release from isolated cat adrenocortical cells.

S G Laychock, R P Rubin.   

Abstract

Prostaglandin (PG) biosynthesis by trypsin-dispersed cat adrenocortical cells was studied by radioimmunoassay (RIA). Parallel assays of incubation media using PGF2alpha and PGF1alpha antisera established that PGF2alpha is the primary PGF released by feline cortical cells. Following the reduction of PGE to PGF with sodium borohydride (NaBH4) these same two antisera were also used to identify PGE2 as the primary PGE released. RIA using a PGE antiserum confirmed the presence of PGE in the incubation medium. Steroidogenic concentrations of ACTH (50-250muU) enhanced PGE and PGF release, and indomethacin suppressed the ACTH-facilitated release. These studies provide additional evidence for ACTH-induced PG synthesis by feline cortical cells, and support the hypothesis that PGs play some role in the steroidogenic action of ACTH.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 183238     DOI: 10.1016/0090-6980(76)90075-7

Source DB:  PubMed          Journal:  Prostaglandins        ISSN: 0090-6980


  3 in total

1.  Identification and partial characterization of phospholipases in isolated adrenocortical cells. The effects of synacthen [corticotropin-(1--24)-tetracosapeptide] and calcium ions.

Authors:  S G Laychock; R C Franson; W B Weglicki; R P Rubin
Journal:  Biochem J       Date:  1977-06-15       Impact factor: 3.857

2.  Observations on the mechanism of bone resorption induced by multiple myeloma marrow culture fluids and partially purified osteoclast-activating factor.

Authors:  R G Josse; T M Murray; G R Mundy; D Jez; J N Heersche
Journal:  J Clin Invest       Date:  1981-05       Impact factor: 14.808

3.  Effect of ACTH and CRH on plasma levels of cortisol and prostaglandin F2alpha metabolite in cycling gilts and castrated boars.

Authors:  A Madej; A M Mwanza; H Kindahl; S Einarsson
Journal:  Acta Vet Scand       Date:  2005       Impact factor: 1.695

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.